SPPI - スペクトラム・ファ―マス―ティカルズ (Spectrum Pharmaceuticals Inc.)

SPPIのニュース

   Spectrum Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Update  2020/11/04 21:00:00 Business Wire
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Update
   Attention Biotech Investors: Mark Your Calendar For These November PDUFA Dates  2020/11/03 21:00:07 Benzinga
The month of October could at best be termed as mixed from the perspective of drug approvals. Avenue Therapeutics Inc's (NASDAQ: ATXI ) pain drug and Zosano Pharma Corp's (NASDAQ: ZSAN ) migraine patch stumbled at the FDA altar. The FDA announced a delay in deciding on Spectrum Pharmaceuticals, Inc.'s (NASDAQ: SPPI ) treatment candidate for chemotherapy-induced neutropenia, citing COVID-19 that impaired its ability to conduct inspections. Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) succeeded in getting its antibody cocktail for Ebola past the finish line. Two new molecular entities, including Gilead Sciences, Inc.'s (NASDAQ: GILD ) Veklury were approved during the month, taking the total NME approvals for the year to 42. PDUFA dates are binary events that invariably serve as make-or-break catalysts for stocks. These dates are deadlines by which the FDA reviews a new drug application before announcing its decision concerning the approvability/non-approvability of the drug. Here are the key PDUFA dates for November.
   The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings  2020/11/01 14:40:39 Benzinga
Biotech stocks continued to sway to the tunes of the broader market in the week ended Oct. 30, which succumbed to geopolitical and macroeconomic concerns. Several big-name pharma companies, including Merck & Co. Inc. (NYSE: MRK ) and Pfizer Inc. (NYSE: PFE ), reported earnings during the week. The earnings news flow was broadly mixed. Catabasis Pharmaceuticals Inc (NASDAQ: CATB ) was among the biggest decliners, as it halted a late-stage trial of its Duchenne muscular dystrophy drug. On the other hand, Scholar Rock Holding Corp. (NASDAQ: SRRK ) was up about over 175% during the week, reacting to positive mid-stage results for spinal muscular atrophy drug. On the COVID-19 front, Regeneron Pharmaceuticals Inc. said it is (NASDAQ: REGN ) halting the Phase 3 trial of its antibody cocktail in patients with severe COVID-19, citing safety issue. Kala Pharmaceuticals Inc. (NASDAQ: KALA ) announced FDA approval for its dry eye disease drug, while Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI ) communicated a delay in the decision for its treatment option for chemotherapy-induced neutropenia, as the FDA could not inspect a plant in South Korea due to COVID-19.
   Neutropenia Treatment Market Top Key Players- Enzychem Lifesciences Corporation, Spectrum Pharmaceuticals, Inc., Tianjin SinoBiotech Ltd., S&D Pharma SK s.r.o., Samsung Medical Center Growth Trends, quantitative analysis Industry Analysis and Market Dynam  2020/10/27 11:17:55 OpenPR
Summary of the Neutropenia Treatment Market Report Due to the various economic, technological, research & development and geographical aspects, the Neutropenia Treatment Market would gain a healthy CAGR and market size from 2020 to 2027. The growth trend would continue to
   Spectrum Pharmaceuticals Announces that the FDA is Deferring its Action on the BLA for ROLONTIS® (eflapegrastim)  2020/10/26 11:00:00 Business Wire
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Announces that the FDA is Deferring its Action on the BLA for ROLONTIS® (eflapegrastim)
   TCOM, PII among premarket gainers  2020/07/28 12:16:54 Seeking Alpha
Eastman Kodak (NYSE:KODK) +190%. Spectrum Pharmaceuticals (NASDAQ:SPPI) +52% on positive poziotinib data in lung cancer. Soligenix (NASDAQ:SNGX) +44% on en
   Spectrum Pops 71% In After-Hours On ‘Positive’ Data For Lung Cancer Treatment  2020/07/28 07:32:37 Smarter Analyst
Shares in Spectrum Pharmaceuticals (SPPI) jumped 71% in extended trading after announcing positive topline results from a Phase 2 clinical trial evaluating its … The post Spectrum Pops 71% In After-Hours On ‘Positive’ Data For Lung Cancer Treatment appeared first on Smarter Analyst .
   Spectrum Pharmaceuticals Announces Positive Topline Results in HER2 Exon20 Insertion Mutations from Cohort 2 of the Poziotinib ZENITH20 Trial  2020/07/27 20:00:00 Business Wire
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Announces Positive Topline Results in HER2 Exon20 Insertion Mutations from Cohort 2 of the Poziotinib ZENITH20 Trial
   Spectrum Pharmaceuticals Presents Same Day Dosing Data for ROLONTIS® (eflapegrastim) at AACR Virtual Annual Meeting II  2020/06/22 13:00:00 Business Wire
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Presents Same Day Dosing Data for ROLONTIS® (eflapegrastim) at AACR Virtual Annual Meeting II
   Spectrum Pharmaceuticals to Present Preclinical ROLONTIS® (eflapegrastim) Same Day Dosing Data at AACR Virtual Annual Meeting II  2020/06/16 11:00:00 Business Wire
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals to Present Preclinical ROLONTIS® (eflapegrastim) Same Day Dosing Data at AACR Virtual Annual Meeting II
   Spectrum Pharmaceuticals Presents Same Day Dosing Data for ROLONTIS® (eflapegrastim) at AACR Virtual Annual Meeting II  2020/06/22 13:00:00 Business Wire
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Presents Same Day Dosing Data for ROLONTIS® (eflapegrastim) at AACR Virtual Annual Meeting II
   Spectrum Pharmaceuticals to Present Preclinical ROLONTIS® (eflapegrastim) Same Day Dosing Data at AACR Virtual Annual Meeting II  2020/06/16 11:00:00 Business Wire
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals to Present Preclinical ROLONTIS® (eflapegrastim) Same Day Dosing Data at AACR Virtual Annual Meeting II
   Why Is Spectrum Pharma (SPPI) Up 6.6% Since Last Earnings Report?  2020/06/06 15:31:48 Zacks Investment Research
Spectrum Pharma (SPPI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
   Spectrum Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference 2020  2020/05/27 11:00:00 Business Wire
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference 2020
   Spectrum Pharmaceuticals to Report First Quarter 2020 Financial Results and Provide Corporate Update  2020/05/01 11:00:00 Business Wire
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals to Report First Quarter 2020 Financial Results and Provide Corporate Update

calendar